Englander Institute for Precision Medicine
Photo credit: Shutterstock

AI Approach Optimizes Embryo Selection for IVF

April 5, 2019

A new artificial intelligence approach by Weill Cornell Medicine investigators, including scientists from the Englander Institute for Precision Medicine, can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy. The technique, which analyzes time-lapse images of the early-stage embryos, could improve the success rate of in vitro fertilization (IVF) and minimize the risk of multiple...

Read More
Source: Shutterstock

Gene Variant and Breast Cancer in Black Women

April 3, 2019

A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

The study, published April 3 in Cancer Epidemiology, Biomarkers & Prevention, found that higher amounts of...

Read More
Photo credit: Cornell University

Nanovaccine boosts immunity in sufferers of metabolic syndrome

March 27, 2019

EIPM Member Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering (MAE) and the Meinig School of Biomedical Engineering (BME), and Matthew Mosquera, an EIPM visiting team member and doctoral student in engineering, along with partners from Cornell University in Ithaca published a very interesting paper on how their nanovaccing aids people with metabolic syndrome. The following article is from ...

Read More